Enhanced susceptibility ofBlymphoma cells to measles virus byEpstein–Barr virus typeIIIlatency that upregulatesCD150/signaling lymphocytic activation molecule-Reference-Cited by-同舟云学术

Enhanced susceptibility ofBlymphoma cells to measles virus byEpstein–Barr virus typeIIIlatency that upregulatesCD150/signaling lymphocytic activation molecule

Published:2014-01-12 Issue:2 Volume:105 Page:211-218
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Takeda Satoshi¹,Kanbayashi Daiki²,Kurata Takako²,Yoshiyama Hironori³,Komano Jun²

Affiliation:

1. AIDS Research Center National Institute of Infectious Diseases TokyoJapan

2. Department of Infectious Diseases Virology Division Osaka Prefectural Institute of Public Health OsakaJapan

3. Research Center for Infection‐associated Cancer Institute for Genetic Medicine Hokkaido University Sapporo Japan

Funder

Japan Health Science Foundation

Japanese Ministry of Health, Labor, and Welfare

Japanese Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12324

Reference60 articles.

1. Oncolytic virotherapy

2. Oncolytic Viruses in the Treatment of Cancer: A Review of Current Strategies

3. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

4. An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

5. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLAM Family Receptors in B Cell Chronic Lymphoproliferative Disorders;International Journal of Molecular Sciences;2024-04-04

2. Sphingomyelin synthase 1 supports two steps of rubella virus life cycle;iScience;2023-11

3. SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy;Frontiers in Immunology;2023-05-11

4. Oncolytic viruses in hematological malignancies: hijacking disease biology and fostering new promises for immune and cell-based therapies;Viral Vectors in Cancer Immunotherapy;2023

5. Measles Virus as an Oncolytic Immunotherapy;Cancers;2021-02-01